恆指倒跌逾300點失28,400 美團及吉利續挫逾5%-7% 惟獲高盛看好瑞聲漲近7%
美國3月PPI年升擴至4.2%創九年半高超預期，但隨著新冠疫苗接種幫助美國經濟從封鎖影響中復甦，市場相信聯儲局將會容許通脹升溫而看好經濟前景，美股三大指數上周五在藍籌股普遍造好下全面高收續升0.5%-0.9%，道指升幅最大並歷來首次觸及33,800關，標普續升0.8%屢創紀錄高。不過，美股期貨全面回吐0.2%，亞太區股市除南韓及台灣股市回升不足0.4%，全部反覆受壓，尤其是憂人行「收水」滬指及深成續跌0.7%及1.2%，分別報3,426及13,650。
恆指繼上周五吐309點或1.1%略重失28,700後，今早在獲高盛升級至「買入」及升價至58元瑞聲(02018.HK)及反壟斷調查結案遭罰182.28億人民幣消除不明朗因素的阿里巴巴(09988.HK)分別高開4.9%及5.5%報41.8元及530元帶動，高開93點或0.3%報28,791欠承接，掉頭失守10天線(28,525)，現造28,387，倒跌311點或1%，成交額558億元。
藍籌股普遍下跌。中汽協及乘聯會上周五數據顯示，內地3月汽車銷量及乘用車市場零售量按年分別升74.9%及67.2%；但乘聯會認為因芯片供給不確定性升溫，料為內地4月汽車生產增量帶來風險。汽車股今早繼續受壓，尤其是藍籌吉利汽車(00175.HK)續挫逾7%報19.18元，股價失守10天線(20.15元)。
美團(03690.HK)及海底撈(06862.HK)連跌第二天，前者今早平開，早段回升至314.6元無以為繼，掉頭一舉跌破10天及20天線(303.6元及313.6元)，最低見295.4元，現造298元，續挫逾5%；後者高開報50元(受制牛熊線50.1元)，掉頭低見46.85元，現造47.75元，續跌3.2%。
騰訊(00700.HK)、小米(01810.HK)、濠賭股銀娛(00027.HK)/金沙(01928.HK)、百威亞太(01876.HK)、蒙牛(02319.HK)、石藥(01093.HK)、中生(01177.HK)及藥明生物(02269.HK)續跌逾2%，前兩者分別報605元及25.05元，股價均失守10天線。
金融股以匯控(00005.HK)、恆生(00011.HK)、友邦(01299.HK)及中銀(02388.HK)沽壓最大，股價續跌1.6%-2%，分別報45.8元、151元、95.1元及26.65。
不過，瑞聲及阿里升幅擴大，最高見42.75元及237.6元，現造42.55元及233.6元，回升6.8%及7.2%。安踏(02020.HK)回升2.5%報134.3元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
